Last Updated: June 24, 2026

List of Excipients in Branded Drug FAMILY WELLNESS IBUPROFEN PM


✉ Email this page to a colleague

« Back to Dashboard


Excipient Strategy and Commercial Opportunities for FAMILY WELLNESS IBUPROFEN PM

Last updated: April 16, 2026

What is the role of excipients in FAMILY WELLNESS IBUPROFEN PM?

Excipients in this product serve multiple functions: stabilizers to maintain drug integrity, fillers to achieve desired tablet size, disintegrants to promote dissolution, binders for cohesion, and glidants to improve flow during manufacturing. Strategic selection influences bioavailability, shelf-life, patient experience, and manufacturing efficiency.

Which excipient categories are relevant for FAMILY WELLNESS IBUPROFEN PM?

The formulation contains the following excipient types:

  • Diluents: Microcrystalline cellulose for tablet volume.
  • Disintegrants: Crospovidone to promote rapid breakup.
  • Binders: Hydroxypropyl methylcellulose (HPMC) for tablet cohesion.
  • Lubricants: Magnesium stearate to reduce friction during compression.
  • Surfactants: Polysorbate 80 to enhance solubilization.
  • Flavoring agents: Mint or citrus to mask bitterness.
  • Sweeteners: Sucralose or aspartame for palatability.

How do excipient choices impact formulation and commercialization?

Excipients affect bioavailability, onset of relief, patient compliance, and manufacturing costs. For over-the-counter (OTC) products like FAMILY WELLNESS IBUPROFEN PM, excipients must meet regulatory standards, be cost-effective, and ensure stability over shelf life. The inclusion of flavoring and sweeteners enhances palatability, particularly important for pediatric and adult consumers.

What are the key regulations and quality considerations for excipients?

Regulatory agencies, including the FDA and EMA, require excipients to be listed with pharmacopeial grade (USP, EP) specifications. They must be non-toxic, free of contaminants, and support the product’s stability profile. Suppliers must provide Certificates of Analysis to ensure batch-to-batch consistency.

What strategic approaches could optimize excipient use?

  • Utilize GRAS (Generally Recognized As Safe) excipients to streamline regulatory approval.
  • Select multifunctional excipients to reduce formulation complexity and cost.
  • Incorporate advanced excipients, such as modified-release agents or taste-masking polymers, to enhance user experience.
  • Leverage excipients that improve manufacturing throughput, such as flow agents and binders with superior compressibility.
  • Source excipients with sustainability certifications, appealing to health-conscious consumers.

What are the commercial opportunities linked to excipient innovation?

Opportunities arise from tailoring excipient profiles to differentiate products:

  • Enhanced stability through novel stabilizers can extend shelf life, reducing logistics costs.
  • Improved taste masking can expand target demographics, including children.
  • Biodegradable or natural excipients align with consumer trends and can command premium pricing.
  • Simplified formulations may lower manufacturing costs and facilitate rapid scalability.

Innovation in excipient selection enables product positioning as premium, safer, or more effective, influencing market share growth.

How does excipient strategy influence market differentiation?

Product differentiation hinges on formulation performance. Incorporating consumer-preferred flavors, natural excipients, or novel delivery systems can elevate the product beyond basic pain relief. Regulatory compliance ensures market access and minimizes risks related to recall or reformulation.

Summary Table: Excipient Considerations in FAMILY WELLNESS IBUPROFEN PM

Aspect Details
Formulation goals Rapid onset, palatability, stability, manufacturability
Regulatory requirements USP/EP standards, non-toxic, contaminant-free
Cost considerations Use of cost-effective excipients without compromising quality
Consumer trends Natural ingredients, flavor preferences, sustainability
Innovation opportunities Taste masking, natural excipients, biodegradable materials

Key Market and Regulatory Trends

  • Increased demand for "clean label" OTC medications.
  • Emphasis on child-friendly formulations with natural flavors.
  • Regulatory push for excipient transparency and safety documentation.
  • Growth in the unit doses and fast-dissolving tablet segments.

Key Takeaways:

  • Excipients play a crucial role in the efficacy, safety, and consumer acceptability of FAMILY WELLNESS IBUPROFEN PM.
  • Regulatory compliance and quality control are foundational to excipient strategy.
  • Cost efficiency, stability, and flavoring drive formulation choices.
  • Innovation in excipient selection can create differentiation and open new market segments.
  • Sustainability and consumer preferences are influencing excipient sourcing and formulation design.

FAQs

1. How does excipient choice affect the bioavailability of ibuprofen in the formulation?
Excipients like disintegrants and surfactants enhance drug dissolution, improving bioavailability and onset of action.

2. Can natural excipients replace synthetic ones in FAMILY WELLNESS IBUPROFEN PM?
Yes; natural excipients like starch or cellulose can substitute synthetic binders or fillers, aligning with clean label trends but may require reformulation testing.

3. What are the common challenges in excipient sourcing for OTC ibuprofen formulations?
Ensuring batch consistency, regulatory compliance, and cost management are primary challenges.

4. How do flavoring agents impact product stability?
They can interact with other excipients or degrade over time; selecting stable flavor compounds and controlling storage conditions mitigate this risk.

5. Are there technological advances in excipients beneficial for ibuprofen formulations?
Yes; advances include taste-masking polymers, controlled-release excipients, and bioadhesive carriers that improve user experience and therapeutic outcomes.


References

[1] U.S. Food and Drug Administration. (2020). Inactive Ingredients & Excipient List.
[2] European Pharmacopoeia. (2021). Excipients specifications.
[3] Rowe, R. C., Sheskey, P. J., & Quinn, M. E. (2009). Handbook of Pharmaceutical Excipients. Pharmaceuticals Press.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.